Hang Yu

1.6k total citations · 2 hit papers
44 papers, 1.1k citations indexed

About

Hang Yu is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, Hang Yu has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 11 papers in Pharmacology and 8 papers in Pharmacology. Recurrent topics in Hang Yu's work include Gut microbiota and health (15 papers), Ginseng Biological Effects and Applications (10 papers) and Pharmacological Effects of Natural Compounds (6 papers). Hang Yu is often cited by papers focused on Gut microbiota and health (15 papers), Ginseng Biological Effects and Applications (10 papers) and Pharmacological Effects of Natural Compounds (6 papers). Hang Yu collaborates with scholars based in China and Hong Kong. Hang Yu's co-authors include Li‐Bin Pan, Jian‐Dong Jiang, Shurong Ma, Ran Peng, Pei Han, Jie Fu, Zhengwei Zhang, Lin Cong, Zhengwei Zhang and Zhenxiong Zhao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Food Chemistry and ACS Applied Materials & Interfaces.

In The Last Decade

Hang Yu

40 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiota

2021 240 citations Yan Wang, Qian Tong et al. Signal Transduction and Targeted Therapy profile →
Berberine treats atherosclerosis via a vitamine-like effect down-regulating Choline-TMA-TMAO production pathway in gut microbiota

2022 120 citations Shurong Ma, Qian Tong et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hang Yu China	17	628	187	162	161	141	44	1.1k
Li‐Bin Pan China	15	639 1.0×	184 1.0×	170 1.0×	190 1.2×	193 1.4×	30	1.1k
Ran Peng China	12	659 1.0×	159 0.9×	192 1.2×	167 1.0×	152 1.1×	28	1.1k
Shurong Ma China	18	782 1.2×	189 1.0×	261 1.6×	226 1.4×	164 1.2×	45	1.3k
Songwei Yang China	18	683 1.1×	132 0.7×	67 0.4×	154 1.0×	85 0.6×	42	1.4k
Tianqiao Yong China	21	950 1.5×	127 0.7×	387 2.4×	216 1.3×	85 0.6×	42	1.6k
Yan Guo China	22	652 1.0×	177 0.9×	79 0.5×	77 0.5×	80 0.6×	78	1.7k
Emre Karakuş Türkiye	23	357 0.6×	121 0.6×	134 0.8×	208 1.3×	35 0.2×	59	1.4k
Ji-Jing Yan South Korea	19	513 0.8×	295 1.6×	160 1.0×	68 0.4×	52 0.4×	35	1.6k
Larissa Staurengo‐Ferrari Brazil	22	525 0.8×	306 1.6×	165 1.0×	221 1.4×	23 0.2×	53	1.5k
Zhou Lan China	19	498 0.8×	174 0.9×	79 0.5×	181 1.1×	26 0.2×	51	1.1k

Countries citing papers authored by Hang Yu

Since Specialization

Citations

This map shows the geographic impact of Hang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hang Yu more than expected).

Fields of papers citing papers by Hang Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hang Yu. The network helps show where Hang Yu may publish in the future.

Co-authorship network of co-authors of Hang Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Hang Yu. A scholar is included among the top collaborators of Hang Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hang Yu. Hang Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pan, Li‐Bin, Ru Feng, Hang Yu, et al.. (2025). Bacteroides fragilis-derived succinic acid promotes the degradation of uric acid by inhibiting hepatic AMPD2: Insight into how plant-based berberine ameliorates hyperuricemia. Acta Pharmaceutica Sinica B. 15(10). 5244–5260. 1 indexed citations

Zhang, Jianli, et al.. (2024). Rapid Liquid Chromatography–Tandem Mass Spectrometry Method for Determination of Total and Free Testosterone in Human Serum and Its Application to Monitoring Biomarker Response of Elite Athletes. Molecules. 29(21). 5007–5007. 1 indexed citations

Fu, Jie, Hang Yu, Hui Xu, et al.. (2024). Berberine promotes the degradation of phenylacetic acid to prevent thrombosis by modulating gut microbiota. Phytomedicine. 128. 155517–155517. 6 indexed citations

Zhang, Xianfeng, Jingyue Wang, Haojian Zhang, et al.. (2024). Dissecting the antitumor effects of Scutellaria barbata: Initial insights into the metabolism of scutellarin and luteolin by gut microbiota. Journal of Pharmaceutical and Biomedical Analysis. 248. 116325–116325.

Yuan, Xinghua, Hang Yu, Yechang Qian, et al.. (2024). Fuzheng Huayu recipe inhibits bleomycin-induced pulmonary fibrosis in rats by inhibiting M2 polarization of macrophages via the oxidative phosphorylation pathway. Journal of Asian Natural Products Research. 27(1). 62–74. 1 indexed citations

Yuan, Shaofeng, Yahui Guo, Hang Yu, et al.. (2023). Carbon dots in breadcrumbs: Effect of frying on them and interaction with human serum albumin. Food Chemistry. 424. 136371–136371. 9 indexed citations

Yu, Hang, et al.. (2023). Metabolic Transformation of Gentiopicrin, a Liver Protective Active Ingredient, Based on Intestinal Bacteria. Molecules. 28(22). 7575–7575. 4 indexed citations

Yu, Hang, Bao‐Ying Wen, Min Huang, et al.. (2023). TCP-1, a novel peptide to diagnose early colon cancer. Chinese Chemical Letters. 35(3). 108235–108235.

Xu, Hui, Hang Yu, Jie Fu, et al.. (2023). Metabolites analysis of plantamajoside based on gut microbiota-drug interaction. Phytomedicine. 116. 154841–154841. 13 indexed citations

10.

Yu, Hang, Hui Xu, Xinyu Yang, et al.. (2023). Gut microbiota-based pharmacokinetic-pharmacodynamic study and molecular mechanism of specnuezhenide in the treatment of colorectal cancer targeting carboxylesterase. Journal of Pharmaceutical Analysis. 13(9). 1024–1040. 18 indexed citations

11.

Xie, Yunfei, et al.. (2022). Progress in the Removal of Pesticide Residues from Fruits and Vegetables by Ozone Technology. SHILAP Revista de lepidopterología. 1 indexed citations

12.

Ma, Shurong, Qian Tong, Yuan Lin, et al.. (2022). Berberine treats atherosclerosis via a vitamine-like effect down-regulating Choline-TMA-TMAO production pathway in gut microbiota. Signal Transduction and Targeted Therapy. 7(1). 207–207. 120 indexed citations breakdown →

13.

Peng, Ran, Pei Han, Jie Fu, et al.. (2022). Esterases From Bifidobacteria Exhibit the Conversion of Albiflorin in Gut Microbiota. Frontiers in Microbiology. 13. 880118–880118. 11 indexed citations

14.

Zhang, Zhengwei, Chunsheng Gao, Heng Zhang, et al.. (2022). Morinda officinalis oligosaccharides increase serotonin in the brain and ameliorate depression via promoting 5-hydroxytryptophan production in the gut microbiota. Acta Pharmaceutica Sinica B. 12(8). 3298–3312. 90 indexed citations

15.

Wang, Yan, Qian Tong, Shurong Ma, et al.. (2021). Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiota. Signal Transduction and Targeted Therapy. 6(1). 77–77. 240 indexed citations breakdown →

16.

Han, Pei, Lisha Li, Zixi Wang, et al.. (2021). Multi-Omics Analysis Provides Insight into the Possible Molecular Mechanism of Hay Fever Based on Gut Microbiota. Engineering. 15. 115–125. 3 indexed citations

17.

Liu, Chang, Peng Du, Yahui Guo, et al.. (2021). Extraction, characterization of aloe polysaccharides and the in-depth analysis of its prebiotic effects on mice gut microbiota. Carbohydrate Polymers. 261. 117874–117874. 79 indexed citations

18.

Zhang, Zhengwei, Lin Cong, Ran Peng, et al.. (2020). Transformation of berberine to its demethylated metabolites by the CYP51 enzyme in the gut microbiota. Journal of Pharmaceutical Analysis. 11(5). 628–637. 38 indexed citations

19.

Pan, Li‐Bin, Pei Han, Shurong Ma, et al.. (2019). Abnormal metabolism of gut microbiota reveals the possible molecular mechanism of nephropathy induced by hyperuricemia. Acta Pharmaceutica Sinica B. 10(2). 249–261. 142 indexed citations

20.

Tian, Yuling, Yan Wu, Lin Yang, et al.. (2017). Pioglitazone stabilizes atherosclerotic plaque by regulating the Th17/Treg balance in AMPK-dependent mechanisms. Cardiovascular Diabetology. 16(1). 140–140. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact